IL6 and cancer: The high cytokine serum levels, such as IL-6 and IL-1, reflect the “cytokine storm,” a familiar event to oncologists, seen in patients with cancer who receive chimeric antigen receptor (CAR) T-cell immunotherapy and, thanks to this knowledge, efficacious treatments with anti-IL-6 monoclonal antibodies have been developed.